
What we know about the illnesses that have sickened over 400 people and killed more than 50 in Congo
KINSHASA, Congo (AP) — Unidentified illnesses in northwestern Congo have killed more than 50 people over the past five weeks, nearly half of them within hours after they felt sick.
The outbreaks in two distant villages in Congo's Equateur province began on Jan. 21 and include 419 cases and 53 deaths. Health officials still do not know the cause, or whether the cases in the two villages, which are separated by more than 120 miles (190 kilometers), are related. It's also unclear how the diseases are spreading, including whether they are spreading between people.
The first victims in one of the villages were children who ate a bat and died within 48 hours, the Africa office of the World Health Organization said this week. More infections were found in the other village, where at least some of the patients have malaria.
Outbreaks in two remote villages
Illnesses have been clustered in two remote villages in different health zones of Equateur province, which is 400 miles (640 kilometers) from Kinshasa.
The first outbreak began in the village of Boloko after three children ate a bat and died within 48 hours. More than two weeks later a second and larger outbreak was recorded in the village of Bomate, where more than 400 people have been sickened. According to WHO's Africa office, no links have been established between the cases in the two villages.
Dr. Serge Ngalebato, medical director of Bikoro Hospital, a regional monitoring center, and one of the government experts deployed to respond to the outbreak, says the situations in the two villages are somewhat different.
'The first one with a lot of deaths, that we continue to investigate because it's an unusual situation, (and) in the second episode that we're dealing with, we see a lot of the cases of malaria,' said Dr. Ngalebato.
The WHO Africa office said the quick progression from sickness to death in Boloko is a key concern, along with the high number of deaths in Bomate.
What are the symptoms?
Congo's Ministry of Health said about 80% of the patients share similar symptoms including fever, chills, body aches and diarrhea.
While these symptoms can be caused by many common infections, health officials initially feared the symptoms and the quick deaths of some of the victims could also be a sign of a hemorrhagic fever such as Ebola, which was also linked to an an infected animal.
However, Ebola and similar diseases including Marburg have been ruled out after more than a dozen samples were collected and tested in the capital of Kinshasa.
The WHO said it is investigating a number of possible causes, including malaria, viral hemorrhagic fever, food or water poisoning, typhoid fever and meningitis.
What is being done in response?
Congo's government says experts have been sent to the villages since Feb. 14, mainly to help investigate the cases and slow the spread.
Ngalebato said patients have been responding to treatments that target the different symptoms.
The remote location of the villages has hindered access to patients while the weak health care infrastructure has made it difficult to carry out surveillance and manage patients. Such challenges are common in disease outbreaks in Congo. In December, an unknown illness killed dozens.
In the latest outbreaks, several victims died even before experts could even reach them, Ngalebato said.
There needs to be an urgent action 'to accelerate laboratory investigations, improve case management and isolation capacities, and strengthen surveillance and risk communication,' the WHO Africa office has said.
Is there a link to Congo's forests?
There have long been concerns about diseases jumping from animals to humans in places where people regularly eat wild animals. The number of such outbreaks in Africa has surged by more than 60% in the last decade, the WHO said in 2022.
Experts say this might be what is happening in Congo, which is home to about 60% of the forests in the Congo Basin, home to the largest expanse of tropical forest on earth.
'All these viruses are viruses that have reservoirs in the forest. And so, as long as we have these forests, we will always have a few epidemics with viruses which will mutate,' said Gabriel Nsakala, a professor of public health at Congo's National Pedagogical University, who previously worked at the Congolese health ministry on Ebola and coronavirus response programs.
___

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
Yahoo
4 hours ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.


CNN
6 hours ago
- CNN
China to make all hospitals offer epidurals to incentivize childbirth
China said that by the end of this year all tertiary level hospitals must offer epidural anesthesia during childbirth, a move it said would help promote a 'friendly childbearing environment' for women. Tertiary hospitals – those with more than 500 beds – must provide epidural anesthesia services by 2025 while secondary hospitals – those containing more than 100 beds – must provide the services by 2027, China's National Health Commission (NHC) said in a statement last week. Authorities are struggling to boost birth rates in the world's second largest economy after China's population fell for a third consecutive year in 2024 with experts warning the downturn will worsen in the coming years. Around 30% of pregnant women in China receive anesthesia to relieve pain during childbirth, compared with more than 70% in some developed countries, the official China Daily said. The World Health Organization recommends epidurals for healthy pregnant women requesting pain relief and it is widely utilized in many countries around the world, including France, where around 82% of pregnant women opt to have one, and in the United States and Canada where more than 67% do. The move will 'improve the comfort level and security of medical services' and 'further enhance people's sense of happiness and promote a friendly childbearing environment,' the NHC said. A growing number of provinces across China are also beginning to include childbirth anesthesia costs as part of their medical insurance schemes to encourage more women to have children. High childcare costs as well as job uncertainty and a slowing economy have discouraged many young Chinese from getting married and starting a family. In June, health authorities in China's southwestern Sichuan province proposed to extend marriage leave up to 25 days and maternity leave up to 150 days, to help create a 'fertility-friendly society.'